D-0178-2026 Class II Ongoing
FDA drug recall D-0178-2026 was initiated by Park Avenue Compounding on Sep 23, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results. The recall status is ongoing. Affected quantity: 189 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 26, 2025
- Initiation Date
- Sep 23, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 189 bags
Product description
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.
Reason for recall
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Distribution pattern
Distributed in Missouri
Code information
Lot # 20250507-01D93C, Exp Date: 11-04-2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0178-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026